AI-informed Colorectal Cancer (CRC) Screening Navigation vs. Standard of Care Among Screening-naive Penn Medicine Patients 45-49 Years Old to Increase CRC Screening Uptake

Abramson Cancer Center at Penn Medicine

Status: Invitation-only

Conditions: Colorectal Cancer

Treatments: Other: Intervention Arm

Study type: Interventional

Funder types: Other

Identifiers

NCT07230795

858875 (Other Identifier)

09225

Details and patient eligibility

About

This project aims to use machine learning algorithms (MLA) to identify and risk-stratify individuals between the ages of 45-49 who are more likely to have colorectal pathology and merit prioritized CRC screening and patient navigation. Patients deemed to be at higher risk for CRC by MLA will be randomized to an intervention group to receive risk-informed patient navigation and a usual care control group. The patient navigation will assist in completing either a fecal immunochemical test (FIT) or a colonoscopy. For the usual care control group, patients may still receive patient navigation for colonoscopy assistance. A referral to a nurse navigator can be initiated by a healthcare staff member in the following ways: 1) procedure scheduling staff will provide navigator's contact number if the patient expresses difficulty with obtaining a ride home 2) endoscopy staff and physicians can message navigator electronically 3) PCPs can place a navigation order in the EHR for patients deemed to need additional support such as with prep, education, transportation 4) providers will directly contact the director of the navigation system (Dr. Carmen Guerra) for referral.

Enrollment: 7,120 estimated patients

Sex: All

Ages: 45 to 49 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Age 45-49
2. Not up to date with CRC screening within the recommended period of time (colonoscopy within 10 years, FIT within 1 year, Cologuard within 3 years, sigmoidoscopy within 3-5 years)
3. Have primary care providers in Penn Internal Medicine and Family Medicine Practices
4. Have at least 1 outpatient CBC in the past 12 months.

Exclusion criteria

1. Prior history of CRC
2. Late-stage cancer of any organ (stage 4)
3. History of colectomy
4. Demonstrated high-risk of colorectal cancer (e.g. inflammatory bowel disease, hereditary colorectal cancer syndromes)

Trial design

Primary purpose: Other

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

7,120 participants in 2 patient groups

Intervention Arm - Navigator Assistance

Experimental group

Description:

A trained CRC navigator who will conduct outreach and navigation by interviewing these patients according to a script that consists of a statement of research, confirms eligibility, communicates their relative increased risk of CRC, assesses and addresses barriers to completion of CRC screening, and offers an adapted validated questionnaire regarding these barriers for patients to complete asynchronously. The navigator will be able to address barriers such as lack of awareness/knowledge about screening, misinformation, negative attitudes and fear, scheduling, inability to afford the prep, and lack of transportation and escort. The calls performed by the patient navigator will not be recorded.

Treatment:

Other: Intervention Arm

Control Arm - NO Navigator Assistance

No Intervention group

Description:

Patients in the control arm will be enrolled under a waiver. They will only receive standard of care.